16.5 USD
+1 (+6.45%)
Overall IZTC gets a fundamental rating of 1 out of 10. We evaluated IZTC against 525 industry peers in the Biotechnology industry. IZTC has a bad profitability rating. Also its financial health evaluation is rather negative. IZTC has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year IZTC has reported negative net income.
1.2 Ratios
- IZTC's Return On Assets of -57.25% is in line compared to the rest of the industry. IZTC outperforms 43.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -57.25% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-53.6%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for IZTC so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- Compared to 1 year ago, IZTC has about the same amount of shares outstanding.
- IZTC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- IZTC has an Altman-Z score of 4.12. This indicates that IZTC is financially healthy and has little risk of bankruptcy at the moment.
- IZTC has a better Altman-Z score (4.12) than 78.51% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.12 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 0.25 indicates that IZTC may have some problems paying its short term obligations.
- Looking at the Current ratio, with a value of 0.25, IZTC is doing worse than 96.45% of the companies in the same industry.
- A Quick Ratio of 0.25 indicates that IZTC may have some problems paying its short term obligations.
- IZTC has a Quick ratio of 0.25. This is amonst the worse of the industry: IZTC underperforms 96.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.25 | ||
| Quick Ratio | 0.25 |
3. Growth
3.1 Past
- The earnings per share for IZTC have decreased strongly by -46.01% in the last year.
EPS 1Y (TTM)-46.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for IZTC. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for IZTC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INVIZYNE TECHNOLOGIES INC / IZTC FAQ
What is the fundamental rating for IZTC stock?
ChartMill assigns a fundamental rating of 1 / 10 to IZTC.
Can you provide the valuation status for INVIZYNE TECHNOLOGIES INC?
ChartMill assigns a valuation rating of 0 / 10 to INVIZYNE TECHNOLOGIES INC (IZTC). This can be considered as Overvalued.
What is the profitability of IZTC stock?
INVIZYNE TECHNOLOGIES INC (IZTC) has a profitability rating of 0 / 10.